Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

The “Albumin Effect” and Drug Glucuronidation: Bovine Serum Albumin and Fatty Acid-Free Human Serum Albumin Enhance the Glucuronidation of UDP-Glucuronosyltransferase (UGT) 1A9 Substrates but Not UGT1A1 and UGT1A6 Activities

Andrew Rowland, Kathleen M. Knights, Peter I. Mackenzie and John O. Miners
Drug Metabolism and Disposition June 2008, 36 (6) 1056-1062; DOI: https://doi.org/10.1124/dmd.108.021105
Andrew Rowland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathleen M. Knights
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter I. Mackenzie
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John O. Miners
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 36 no. 6 1056-1062
DOI 
https://doi.org/10.1124/dmd.108.021105
PubMed 
18362158

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received February 17, 2008
  • Accepted March 20, 2008
  • Published online May 19, 2008.

Article Versions

  • Earlier version (March 24, 2008 - 09:11).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Andrew Rowland,
  2. Kathleen M. Knights,
  3. Peter I. Mackenzie and
  4. John O. Miners
  1. Department of Clinical Pharmacology, Flinders University and Flinders Medical Centre, Bedford Park, Adelaide, Australia
  1. Address correspondence to:
    Dr. John Miners, Department of Clinical Pharmacology, Flinders Medical Centre, Bedford Park, SA 5042, Australia. E-mail: john.miners{at}flinders.edu.au
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: March 2008 to January 2021

AbstractFullPdf
Mar 2008550113
Apr 2008340181
May 20087611110
Jun 2008813677
Jul 2008482033
Aug 2008463246
Sep 2008672129
Oct 2008373247
Nov 2008381633
Dec 2008241322
Jan 2009121523
Feb 2009261520
Mar 2009292436
Apr 2009172428
May 2009192628
Jun 2009153037
Jul 2009111014
Aug 2009152622
Sep 2009182321
Oct 2009422129
Nov 2009362034
Dec 200937324
Jan 2010522021
Feb 2010362623
Mar 2010402531
Apr 2010362423
May 2010582520
Jun 2010393028
Jul 2010391015
Aug 20101291617
Sep 2010262219
Oct 2010481522
Nov 2010401920
Dec 2010361612
Jan 2011322426
Feb 2011302113
Mar 2011302935
Apr 2011182222
May 2011291626
Jun 2011411630
Jul 2011261316
Aug 2011401623
Sep 2011372022
Oct 2011411824
Nov 2011371829
Dec 201148109
Jan 2012341315
Feb 2012622031
Mar 2012561733
Apr 2012491525
May 2012371316
Jun 2012322631
Jul 2012511626
Aug 2012452644
Sep 2012322530
Oct 2012373425
Nov 2012352530
Dec 2012251520
Jan 2013612522
Feb 2013382617
Mar 2013332723
Apr 2013462220
May 2013432830
Jun 2013411516
Jul 2013272026
Aug 2013211725
Sep 2013391510
Oct 2013452629
Nov 2013331918
Dec 20132399
Jan 201441136
Feb 2014301537
Mar 2014403727
Apr 2014272825
May 2014353630
Jun 2014352017
Jul 2014384119
Aug 2014231614
Sep 2014352425
Oct 2014471316
Nov 20143598
Dec 2014221720
Jan 201527910
Feb 20151676
Mar 2015302022
Apr 201530159
May 2015411820
Jun 2015263531
Jul 2015382627
Aug 201522137
Sep 201520149
Oct 201522910
Nov 201514456
Dec 2015122016
Jan 2016192819
Feb 2016212212
Mar 201617917
Apr 2016161416
May 2016241821
Jun 2016272040
Jul 2016211518
Aug 2016172517
Sep 2016211712
Oct 201692612
Nov 2016101915
Dec 201673014
Jan 201763413
Feb 201763319
Mar 201753011
Apr 201722211
May 201772619
Jun 201752210
Jul 201743624
Aug 201754125
Sep 20176189
Oct 201754114
Nov 201775015
Dec 20174121
Jan 201842910
Feb 201824615
Mar 2018325720
Apr 201821767
May 201807511
Jun 2018010412
Jul 201817018
Aug 201803315
Sep 20180319
Oct 201806540
Nov 201819314
Dec 201883189
Jan 2019701219
Feb 20198178
Mar 20193152
Apr 201931911
May 201922811
Jun 20191677
Jul 20191545
Aug 20192074
Sep 20192243
Oct 20193426
Nov 20193687
Dec 2019342012
Jan 202031137
Feb 20203899
Mar 2020281413
Apr 202046713
May 20202313
Jun 20201510
Jul 20202424
Aug 202027610
Sep 202026122
Oct 202023152
Nov 20203123
Dec 202030103
Jan 202123252

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 36 (6)
Drug Metabolism and Disposition
Vol. 36, Issue 6
1 Jun 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The “Albumin Effect” and Drug Glucuronidation: Bovine Serum Albumin and Fatty Acid-Free Human Serum Albumin Enhance the Glucuronidation of UDP-Glucuronosyltransferase (UGT) 1A9 Substrates but Not UGT1A1 and UGT1A6 Activities
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

The “Albumin Effect” and Drug Glucuronidation: Bovine Serum Albumin and Fatty Acid-Free Human Serum Albumin Enhance the Glucuronidation of UDP-Glucuronosyltransferase (UGT) 1A9 Substrates but Not UGT1A1 and UGT1A6 Activities

Andrew Rowland, Kathleen M. Knights, Peter I. Mackenzie and John O. Miners
Drug Metabolism and Disposition June 1, 2008, 36 (6) 1056-1062; DOI: https://doi.org/10.1124/dmd.108.021105

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

The “Albumin Effect” and Drug Glucuronidation: Bovine Serum Albumin and Fatty Acid-Free Human Serum Albumin Enhance the Glucuronidation of UDP-Glucuronosyltransferase (UGT) 1A9 Substrates but Not UGT1A1 and UGT1A6 Activities

Andrew Rowland, Kathleen M. Knights, Peter I. Mackenzie and John O. Miners
Drug Metabolism and Disposition June 1, 2008, 36 (6) 1056-1062; DOI: https://doi.org/10.1124/dmd.108.021105
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • BSEP Function in Suspension Hepatocytes
  • Candesartan glucuronide serves as a CYP2C8 inhibitor
  • Role of AADAC on eslicarbazepine acetate hydrolysis
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics